RA is opening my eyes to the complex world of high level, biological medicines. According to one source, the global market for TNF inhibitors (e.g. Enbrel, Humira, etc.) was $13.5 billion in 2008. Understandably, it takes years of research, clinical trials, and approval processes in multiple countries before a new medication hits the market. And recouping those costs is important since the pharmaceutical companies have so much invested. But these dollar amounts amaze me when I consider the exorbitant retail price (about $1,800 a month) and the fact that the FDA gives a 14 year lock on biologicals before making it generic (7 years for other drugs).
Please consider making a donation to Rheumatoid Arthritis Guy.
- People Magazine: Megan Park: Living With Rheumatoid Arthritis Has Made Me ‘More Empathetic’ As An ActorJune 5, 2015 - 10:30 am
- Accepting Chronic Pain: Is it Necessary?March 27, 2015 - 9:09 am
- Harvard Gazette: A Journey Into IllnessJanuary 12, 2015 - 4:19 pm
- Health.com: 11 Famous People With RAOctober 1, 2014 - 9:50 am
- Arthritis Broadcast Network: Spotlight On Arthritis SuperheroesSeptember 10, 2014 - 7:34 pm